- Home
- VERU
VERU
Veru Inc.
as 05-23-2025 4:00pm EST
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
| Founded: | 1971 | Country: | United States |
| Employees: | N/A | City: | MIAMI |
| Market Cap: | 76.9M | IPO Year: | 1990 |
| Target Price: | $4.00 | AVG Volume (30 days): | 856.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.25 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.45 - $1.42 | Next Earning Date: | 05-08-2025 |
| Revenue: | $16,886,419 | Revenue Growth: | 134.43% |
| Revenue Growth (this year): | -82.48% | Revenue Growth (next year): | N/A |
Latest Veru Inc. News
VERU Breaking Stock News: Dive into VERU Ticker-Specific Updates for Smart Investing
GuruFocus.com
15 days ago
Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial ...
GlobeNewswire
16 days ago
Veru Participates in a Virtual Investor KOL Connect Segment
GlobeNewswire
16 days ago
Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress
GuruFocus.com
16 days ago
Veru Inc (VERU) Q2 2025 Earnings Report Preview: What To Look For
GlobeNewswire
23 days ago
Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8
GlobeNewswire
a month ago
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit
Simply Wall St.
2 months ago
Compass Therapeutics And 2 More Compelling Penny Stocks
GlobeNewswire
2 months ago
Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference
Compare VERU vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VERU Veru Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.